Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Acq. announced Quarterly results Director comp. Director departure Appointed director CC transcript
|
CIGNA CORP (CI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
12/20/2018 |
8-K
| Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-B...
Docs:
|
"Amended and Restated Certificate of Incorporation of Cigna Holding Company (formerly known as Cigna Corporation)",
"Amended and Restated By-Laws of Cigna Holding Company (formerly known as Cigna Corporation)",
"Second Supplemental Indenture, by and among Express Scripts Holding Company, Cigna Holding Company (formerly known as Cigna Corporation) and U.S. Bank National Association, as Trustee, to that certain base indenture, by and among Halfmoon Parent, Inc. (now known as Cigna Corporation) and U.S. Bank National Association (as supplemented by that certain first supplemental indenture thereto dated as of September 17, 2018)",
"Additional Guarantor Supplement, by Express Scripts Holding Company and Cigna Holding Company (formerly known as Cigna Corporation) to that certain Revolving Credit and Letter of Credit Agreement, by and among Cigna Corporation (now known as Cigna Holding Company), Halfmoon Parent, Inc. (now known as Cigna Corporation), JPMorgan Chase Bank, N.A., as administrative agent, and the other parties thereto",
"Additional Guarantor Supplement, by Express Scripts Holding Company and Cigna Holding Company (formerly known as Cigna Corporation) to that certain Term Loan Credit Agreement, by and among Cigna Corporation (now known as Cigna Holding Company), Halfmoon Parent, Inc. (now known as Cigna Corporation), Morgan Stanley Senior Funding, Inc., as administrative agent, and the other parties thereto",
"Supplemental Indenture No. 11, by and among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), Cigna Holding Company (formerly known as Cigna Corporation) and U.S. Bank National Association, as Trustee, to that certain base indenture, by and among Cigna Corporation (now known as Cigna Holding Company) and U.S. Bank National Association, as Trustee",
"Supplemental Indenture No. 1, by and among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), Cigna Holding Company (formerly known as Cigna Corporation) and HSBC Bank USA, National Association (as successor to Marine Midland Bank, N.A.), as Trustee, to that certain base indenture, by and among Cigna Corporation (now known as Cigna Holding Company) and HSBC",
"Supplemental Indenture No. 1, by and among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), Cigna Holding Company (formerly known as Cigna Corporation) and Deutsche Bank Trust Company Americas, a New York banking corporation (as successor to Bankers Trust Company), as Trustee, to that certain base indenture, by and among Cigna Corporation (now known as Cigna Holding Company) and Deutsche Bank",
"Cigna Completes Combination with Express Scripts, Establishing a Blueprint to Transform the Health Care System" |
|
12/19/2018 |
8-K
| Regulation FD Disclosure |
12/13/2018 |
8-K
| Regulation FD Disclosure |
12/10/2018 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
11/21/2018 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits |
11/21/2018 |
8-K
| Regulation FD Disclosure |
11/01/2018 |
8-K
| Quarterly results |
09/27/2018 |
8-K
| Quarterly results |
09/21/2018 |
8-K
| Acquisition/merger/asset purchase announced
Docs:
|
"Indenture, between Halfmoon Parent, Inc. and U.S. Bank National Association, as trustee",
"Supplemental Indenture, between Halfmoon Parent, Inc. and U.S. Bank National Association, as trustee",
"Registration Rights Agreement, by and among Halfmoon Parent, Inc. and Morgan Stanley & Co. LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the Initial Purchasers named in Schedule I to the Purchase Agreement" |
|
09/17/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
09/11/2018 |
8-K
| Regulation FD Disclosure |
09/04/2018 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
08/29/2018 |
8-K
| Regulation FD Disclosure |
08/24/2018 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
08/21/2018 |
8-K
| Regulation FD Disclosure |
08/13/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
08/10/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
08/09/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
08/08/2018 |
8-K
| Investor presentation |
08/07/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
08/02/2018 |
8-K
| Quarterly results |
07/02/2018 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs:
|
"Amendment No. 1, to the Agreement and Plan of Merger, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc",
"BLOOMFIELD, Conn. – July 2, 2018 –" |
|
05/31/2018 |
8-K
| Regulation FD Disclosure |
05/03/2018 |
8-K
| Quarterly results |
04/30/2018 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
04/25/2018 |
8-K
| Quarterly results |
04/23/2018 |
8-K
| Quarterly results |
04/12/2018 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
03/15/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
03/13/2018 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financi... |
03/08/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
02/27/2018 |
8-K
| Regulation FD Disclosure |
02/01/2018 |
8-K
| Quarterly results
Docs:
|
"Adjusted income from operations 1 for 2017 was $2.7 billion, or $10.46 per share o Total revenues are expected to grow 7% to 8% in 2018, with projected growth of 300,000 to 500,000 global medical customers 2 o Adjusted income from operations 1,3 is projected to be in the range of $3.08 billion to $3.20 billion in 2018, or $12.40 to $12.90 per share 4 , which represents per share growth of 19% to 23% over 2017 BLOOMFIELD, CT, February 1, 2018" |
|
01/09/2018 |
8-K
| Quarterly results |
|
|
|